The journal retracts the 2020 article cited above.
Following publication, Frontiers was alerted to the presence of non-verifiable cell line identifiers in this publication. Upon further examination, it was determined that core findings of this study were obtained using non-verifiable cell lines and/or cell lines known to be cross-contaminated with HeLa. This contamination compromises the data and conclusions of the article and the article has been retracted.
This retraction was approved by the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and agree to this retraction. This communication has been recorded by the publisher.
Summary
Citation
Frontiers Editorial Office (2024) Retraction: FNDC1 promotes the invasiveness of gastric cancer via Wnt/β-catenin signaling pathway and correlates with peritoneal metastasis and prognosis. Front. Oncol. 14:1490592. doi: 10.3389/fonc.2024.1490592
Received
03 September 2024
Accepted
03 September 2024
Published
16 September 2024
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
14 - 2024
Updates
Copyright
© 2024 Frontiers Editorial Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.